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The presence of a leader peptide in picornaviruses is restricted to the Cardiovirus and Aphthovirus genera. 
However, the leader peptides of these two genera are structurally and functionally unrelated. The aphthovirus 
leader is a protease involved in viral polyprotein processing and host cell translation shut off. The function of 
the cardiovirus leader peptide is still unknown. To gain an insight into the function of the caidiovnus leader 
peptide, a mengovirus leader peptide deletion mutant was constructed. The deletion mutant was able to giow  
at a reduced rate in baby hamster kidney cells (BHK-21). Mutant virus production in mouse fibroblasts (L929 
cells), however, could be demonstrated only after inoculation of BHK-21 cells with the transfected L929 cells. 
Analysis of cellular and viral protein synthesis in mutant virus-infected cells showed a delayed inhibition of 
host cell protein synthesis and a reduced production of viral proteins. In a single-cycle infection, mutant virus 
produced only 1% of wild-type virus yield at 8 h postinfection. Host cell translation shutoff in L929 cells infected 
with mutant virus was restored by the addition of the kinase inhibitor 2-aminopurine. Mutant virus production 
in 2-aminopurine-treated L929 cells was increased to 60% of wild-type virus yield at 8 h postinfection. Our 
results suggest that the cardiovirus leader peptide is involved in the inhibition of host cell protein synthesis.
The picornavirus family can be subdivided into five different 
genera, the enteroviruses, rhinoviruses, cardioviruses, aphtho- 
viruses, and hepatoviruscs. They all possess a single-stranded 
RNA genome of approximately 7.5 kb with positive polarity 
which contains an unusual long 5' nontranslated region (57 
NTR), a 3' NTR at their 3' end, and a genetically encoded 
poIy(A) tract. The RNA genome is functionally equivalent to 
cellular mRNA and encodes a single polyprotein of approxi­
mately 220 kDa, which is subsequently processed by virus- 
encoded proteases into the structural and nonstructural viral 
proteins (12). The polyprotein comprises the PI region con­
taining the structural proteins that form the viral capsid and 
the P2 and P3 regions that deliver the nonstructural proteins 
involved in virus translation and replication. Poliovirus is the 
best studied of the picornaviruses, but the specific protein 
functions seem to be similar in all genera within this family 
with the notable exception of the 2A proteins and the leader 
peptides. The enteroviruses and rhinoviruses contain a 2A 
protein of 16 kDa which possesses proteolytic activity (8). In 
contrast, the aphthovirus 2A peptide consists of 19 amino acid 
residues that are involved in the nonenzymatic cleavage of the 
virus polyprotein at the 2A-2B junction (13). Aphthoviruses 
contain a leader peptide located upstream of the PI region, 
while the enteroviruses and rhinoviruses lack the leader pep­
tide. Cardioviruses, on the other hand, contain both leader and 
2A proteins.
The 2A protease (2Apro) of the enteroviruses and rhinovi­
ruses and the leader protease (Lpro) of aphthoviruses exhibit 
similar activities. 2Apro cleaves at its N terminus at the VP1-2A 
junction while Lpro cleaves at its C terminus at the L-VP4 
junction. The enterovirus and rhinovirus 2Apro is a zine-bind- 
ing protein which also causes the proteolytic degradation of the
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220-kDa subunit of the eukaryotic translation initiation factor
4 (eIF-4G) (8,17). The leader proteasc (Lpm) of aphthoviruses 
exhibits similar activity (5). As a consequence of eIF-4G deg­
radation, translational initiation of cellular, 5'-capped mRNAs 
will be inhibited whereas initiation of viral translation is me­
diated by an internal ribosome entry site within the 5' NTR, 
independent of a 5 '-cap structure (2). 2Apro and IJlin are also 
probably involved in the interaction between one or several 
cellular factors and the 5' NTR of the viral RNA to enhance 
viral translation initiation (3, 22). In contrast to the other 
picornaviruses, no degradation of eIF-4G occurs during car­
diovirus infection. Recently, Chen ct al. demonstrated that, 
like enterovirus and rhinovirus 2Aprc\  the Theilcr’s encepha­
lomyelitis virus (TMEV) L peptide contains a zinc-binding 
motif (1, 17), the presence of which might indicate that the L 
peptide possesses nucleic acid binding properties. However, 
the biological function of the cardiovirus leader is still un­
known. Kong et al. recently constructed a series of TMEV DA 
strain deletion mutants lacking parts of the leader peptide- 
encoding region and showed that, whereas the leader peptide 
is dispensable for TMEV growth in baby hamster kidney 
(BHK-21) cells, growth in mouse fibroblasts (L929 cells) was 
dependent on a functional L peptide, suggesting that host cell 
restriction of virus growth was due to the production of inter­
feron by L929 cells (6).
In this paper, we describe a deletion mutant of mengovirus, 
which lacks leader peptide activity. Cellular and viral protein 
syntheses were studied in both BHK-21 and L929 cells in the 
presence or absence of fibroblast interferon and the kinase 
inhibitor 2-aminopurine (18, 23). We found that deletion of 
the leader peptide resulted in host cell-restricted virus growth. 
Host cell protein synthesis shutoff was delayed in cells infected 
with mutant virus. The presence of 2-aminopurine in mutant 
virus-infected L929 cells resulted in restored shutoff of host 
cell protein synthesis whereas production of mutant virus was 
increased. The results reported here suggest that the cardiovi-
4948
VOL. 70, 1996 MENGOVIRUS LEADER AND INHIBITION OF PROTEIN SYNTHESIS 4949
virus yield (log TCID50/ml)
8 □
7
u
8 10
hours post infection
FIG. 1. Single-cycle growth curves in BHK-21 cells of vM16.1 (□ ) and 
vMl(UAL( 12-52) (*) and in L929 cells o f  vM 16.1 ( + )  and vM16.1AL(12-52) (0 ) .  
Cells were infected with virus at an MOI of I. Cultures were incubated at 36 C. 
and harvested at 4, 6, and 8 h postinfection. Virus titers were determined by 
titration on BHK-21 cells at 36°C.
rus leader protein is involved in the inhibition of host cell 
protein synthesis.
MATERIALS AN1) METHODS
Cells and viruses. BHK-21 cells and L929 cells were used for RNA transfec­
tions, virus propagation, and plaque assays. Production of virus stocks and virus 
titrations were perform ed in BHK-21 cells. Virus titers were determined with 
eight replicates by titrating decimal dilutions in 96-well microtiter plates (16). 
Fifty percent tissue culture infective doses (TC ID 5{)) were calculated according 
to the method of' R eed and Muench (11).
Construction of the L deletion m utant. The infectious mengovirus cDNA 
clone p M I6.1 (2) was kindly provided by A. Palmenberg (University of Wiscon­
sin). Site-directed mutagenesis was performed with the Altered Sites in vitro 
mutagenesis system according to the instructions of the manufacturer (Pro- 
mega). To achieve mutagenesis, the EcoRV-Smal fragment (nucleotides 45 to 
3847) from pM 16 .1 was lirsl cloned into the Smal site of pALTER-1, which 
resulted in the clone pA LTER-M L. Then, unique XhoI cleavage sites were 
introduced into the L-encoding region at positions 749 and 870 with the mu­
tagenesis oligonucleotides 5'-C.CA TTC TTC AAA G G T  CAT G G C T C G  AGC 
ACA AAT CTC TTG TTC -3 ' and 5 '-C A A  A TC AGG ATC GAA CAC TCG 
AGC TTC ACC A T C  A G T  CAA CGA-3' (Isogen, Amsterdam, The N ether­
lands),
The Bln\-Bgl\\ fragment (nucleotides 296 to 3814) of the original pM16.1 
cDNA clone was replaced by the Blnl-Bglll fragment of the mutated pAL 
TER-ML constructs. T he deletion m utant was created by Xhol digestion and 
subsequent self-ligation. The construct was verified by sequence analysis using 
the Ampli Cycle sequencing kit according to the m anufacturer’s instructions 
(Pcrkin-Elmer). The m utant mengovirus cDNA clone pM16.1AL(12-52), which 
lacks the region which encodes amino acids 12 to 52 of the leader peptide, was 
obtained with this procedure.
In vitro transcrip tion  and transfection* BHK-21 and L929 cells were trans­
fected with 2 to 4 jig o f in vitro-lranscribed RNA  by the DEAE-dextran method 
(19) with some modifications. Briefly, copy RNA  in a volume of 20 |il was mixed 
with 150 fj.1 of H E PE S  (N-2-hydroxyethylpiperazine-Af'-2-ethanesulfonic acid)- 
buffcred saline solution (containing 20 mM H EPES [pH 7.05], 137 mM NaCl, 5 
mM KCl, 0.7 mM N aH 2P 0 4> and 5.5 mM glucose) and 150 jjl! of 1-mg/ml 
DEAE-dextran in HEPES-buffered saline solution and incubated on ice for 30 
min. BHK-21 or L929 cells grown in 25-cirr flasks were washed three times with 
phosphate-buffered saline (PBS) (pH 7.4) and incubated with the R N A -D EA E- 
dextran mixture at room tem perature for 30 min. Monolayers were washed three 
times with PBS and subsequently incubated at 36°C in the appropriate cell 
culture medium. Transfected cells were maintained for up to 5 days or until 
complete cytopathic ciTect due to virus growth was observed and subjected to 
three cycles of freezing and thawing. Lysates of cells transfected with mutant 
RNA were used to inoculate fresh cells when described. Aliquots of virus slocks 
were stored al -JS0°C.
Plaque assay. Plaque assays of both wild-type and deletion mutant virus were 
performed with 100% confluent monolayers of BHK-21 and L929 cells on 10-cirr 
dishes. Cells were infected with various virus dilutions and incubated at room 
temperature for 30 min. A fter removal of the inoculum, L929 cells were overlaid 
with 5 ml of medium containing 1% plaque agarose (Servo) and neutral red and
grown for 3 to 5 days. Because of the irregular structure of BHK-21 monolayers, 
a modified procedure for the plaque assay on these cells was used. Briefly, 
BHK-21 cells were overlaid with 5 ml of medium containing \ % methylcellulosc. 
To visualize the plaques generated on BHK-21 cells, the methylcellulosc overlay 
was removed 3 days after infection and the cells were washed three times with 
PBS. The cells were fixed with 100% methanol and stained by Giemsa. The 
plaque assays were performed at 33, 36, and 39°C.
Single-cycle growth curves. Monolayers (25 cm2) o f  BHK-21 and L929 cells 
were inoculated with vM16.1 and vM16.1AL(l2-52) at a multiplicity of infection 
(M O I) of 1 T C 1D5() per cell. Virus suspensions were replaced by fresh culture 
medium after 30 min of absorption at 36°C. A t specific times postinfection as 
indicated in the text, cells were disrupted by three cycles of freezing and thawing. 
Virus titers were determ ined by titration of the supcrnatants on BHK-21 cells.
Analysis of protein synthesis in vivo. Monolayers o f  BHK-21 and L929 cells 
were inoculated with vMl6.1 and vM!6.1AL(12-52) at an MOI of 50 TC ID 5(} per 
cell. Virus suspensions were replaced by fresh medium after 30 min of absorption 
at 36°C. A t various times postinfection, monolayers were washed three times 
with PBS (pH 7.2). Cells were incubated for 1 h with methionine-free medium 
containing 10 |xCi of [35S]Met per ml (ICN). Cellular extracts were prepared by 
lysis with a buffer containing 0.5 M Tris-HCl (pH 8,0), 0.15 M sodium chloride, 
1% Nonidet P-40, 0.05% sodium dodecyl sulfate (SDS), and 0.1 mM phenyl- 
methylsulfonyl fluoride. Protein synthesis was further analyzed by SDS-polyacryl- 
amide gel electrophoresis and autoradiography.
Treatm ent of L929 cells with interferon an d  2-aminopurine, Monolayers of 
L929 cells were treated 2 h prcinfection with 100 U of mouse fibroblast inter­
feron per ml (Sigma). 2-Aminopurinc (Sigma) was dissolved to a final concen­
tration of 150 mM in PBS containing 0.5% acetic acid. Aliquots of this stock 
solution were stored at -80°C . Cells were treated with 2-aminopurinc at a 
concentration of 10 mM 2 h preinfection.
RESULTS
Construction of the leader peptide deletion mutant. At first 
instance, we deleted the complete L peptide-encoding region 
from the infectious cDNA clone of mengovirus pM16.1 (2). 
However, in vitro translation of the mutant copy RNA re­
vealed that viral protein synthesis was markedly reduced (data 
not shown). It has indeed been reported that translation initi­
ation efficiency of encephalomyocarditis virus depends on the 
nucleotide sequence just downstream from the start codon (4). 
Therefore, to avoid problems in translation initiation not re­
lated to L activity, unique Xhol sites were introduced at posi­
tions 749 and 870 on pM16.1. Digestion with Xhol and subse­
quent self-ligation of the mutated cDNA resulted in the 
construct pM 16.1AL( 12-52), in which amino acids 12 to 52 of 
the L peptide were deleted.
Characterization of the leader peptide deletion mutant. In 
vitro-transcribed RNA of both pM16.1 wild-type and mutated 
cDNA was used for transfection of BHK-21 cells and L929 
cells. Transfection of both these cell lines with wild-type copy 
RNA resulted in complete cell lysis within 24 h. Transfection 
of BHK-21 cells with pM16,lAL(12-52) copy RNA resulted in 
a cytopathic effect within 3 days. No cytopathic effect was 
observed after transfection of L929 cells with pM16.1AL(12- 
52) copy RNA, Inoculation of BHK-21 with the lysate of trans­
fected L929 cells, however, resulted in a cytopathic effect 
within 3 days. Subsequent virus characterizations were per­
formed with mutant virus vMl 6,1 AL(12-52) stocks produced in 
BHK-21 cells. Titration of mutant virus with L929 cells re­
vealed that a cytopathic effect could be observed only after 
infection at an MOI of at least 10. On the other hand, infection 
of BHK-21 cells with mutant virus at an MOI of 10-4 resulted 
in complete cytopathic effect within 3 days. Viral growth ki­
netics were measured by single-cycle growth curves (Fig. 1). 
Mutant virus yields in both cell types at 8 h after infection were 
approximately 1 % of those of the wild-type virus. Plaque assays 
were performed in BHK-21 cells and L929 cells. Plaques of 2 
to 3 mm were obtained with wild-type virus in L929 cells at 5 
days postinfection. However, no plaques were observed when 
vM16.1AL(12-52) was inoculated on L929 cells (Fig. 2). Be­
cause of the irregular structure of the cellular monolayer, 
BHK-21 cells cannot be maintained for more than 3 days after
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though the mechanism of enhancement of translation is still 
unknown, binding of the 2A protein to the viral RNA may be 
essential in this process. A number of translation initiation 
factors and other cellular proteins, like the polypyrimidine- 
binding protein and the La autoantigen, are involved in the 
translation initiation of the picornaviral RNA (7, 20). Viral 
peptides may be necessary to recruit these cellular factors or 
mediate binding of the cellular proteins to the viral RNA. The 
function of the cardiovirus leader peptide may be similar to the 
function of the enterovirus 2A and the aphthovirus L proteins. 
Binding of the cardiovirus leader peptide to the viral RNA may 
be necessary for the recruitment of one or more cellular factors 
involved in viral translation. The affinity of cellular translation 
initiation factors for the cardiovirus internal ribosome entiy 
site may be enhanced by the leader peptide. This enhancement 
may be essential especially when a restricted host factor is 
involved. Scheper et al. indeed reported that inhibition of host 
cell translation in cardiovirus-infectcd cells depends partly on 
competition between viral RNA and cellular mRNA for re­
stricted host factors, like eIF-2B (15). Early in infection, only 
minor amounts of viral RNA are present. So, leader peptide- 
mediated binding may be essential if host cell translation is to 
be shut off. The cardiovirus leader peptide seems to be in­
volved in this inhibition of host cell protein synthesis, but the 
way in which the protein acts still remains to be elucidated.
ACKNOWLEDGMENT
We thank Peter Donnelly for critical comments on the manuscript.
REFERENCES
1. Chen, H. II., W. P. Kong, and R. P. Roos. 1995. The leader peptide of 
Thuilcr’s. murine encephalomyelitis virus is a zinc-binding protein, J. Virol. 
69:KI)7Mi()78.
2. Duke, G. M., and A. C. Palmenberg. 1989. Cloning and synthesis of infectious 
cardiovirus RNAs containing short, discrete poly(C) tracts. J. Virol. 63:1822- 
lK2f).
3. Hambidge, S. J., and P. Sarnow. 1992. Translational enhancement of the 
poliovirus 5' noncoding region mediated by virus-encoded polypeptide-2A. 
Proc. Natl. Acad. Sci. USA 89:10272-10276.
4. Kaminski, A., G. J. BeJsham, and R. J. Jackson. 1994. Translation of en­
cephalomyocarditis virus RNA: parameters influencing the selection of the 
internal initiation site. EMBO J. 13:1673-1681.
5. Kircliweger, R., E. Ziegler, B. J. Lamphear, D, Waters, H. D. Liebig, W.
Sommergruber, F. Sobrino, C. Hohenadl, D. Blaas, R. E. Rhoads, and T.
Skcrn. 1994. Foot-and-mouth disease virus leader proteinase: purification of
the Lb form and determination of its cleavage site on eIF-4^. J Virol 
68:5677-5684.
6 . Kong, W. P., G. D. Ghadge, and R. P. Roos. 1994. Involvement of cardiovirus
leader in host cell-restricted virus expression. Proc. Natl. Acad. Sci. USA 
91:1796-1800.
7. Meerovitch, K., Y. V. Svitkin, H. S. Lee, F. Leibkowicz, D. J. K enan, E. K. L. 
Chan, V. I. Agol, J. D. Keene, and N. Sonenberg. 1993. La autoantigen 
enhances and corrects aberrant translation of poliovirus R N A  in reticulocyte 
lysate. J. Virol. 67:3798-3807.
8. Merrick, W. C. 1992. Mechanism and regulation of eukaryotic protein syn­
thesis. Microbiol. Rev. 56:291-315.
9. Munoz, A., and L. Carrasco. 1981. Protein synthesis and m em brane integrity 
in interferon-treated HeLa cells infected with encephalomyocarditis virus. 
J. Gen. Virol. 56:153-162.
10. O’Neill, R. E., and V. R< RacanielJo. 1989. Inhibition of translation in cells 
infected with a poliovirus 2Apr" mutant correlates with phosphorylation of 
the alpha subunit of eucaryotic initiation factor 2. J. Virol. 63:5069-5075.
11. Reed, L. J., and H. A. Muench. 1938. A simple method of estimating fifty 
percent endpoints. Am, J. Hyg. 27:493-497.
12. Rucckeri, R. R. 1990. Picornaviridae and their replication, p. 507-547. In 
B. N. Fields (ed.), Virology. Raven Press, New York.
13. Ryan, M. D., A. M. Q. King, and G. P. Thomas. 1991. Cleavage of foot-and- 
mouth disease virus polyprotein is mediated by residues located within a 19 
amino acid sequence. J. Gen. Virol. 72:2727-2732.
14. Samuel, C. E. 1991. Antiviral actions of interferon; interferon-regulated 
cellular proteins and their surprisingly selective antiviral activities. Virology 
183:1-11.
15. Scheper, G. C., A. A. M. Thomas, and H. O. Voorma. 1991. T he 5' untrans­
lated region of encephalomyocarditis virus contains a sequence for very 
efficient binding of eukaryotic initiation factor e!F-2/2B. Biochim. Biophys. 
Acta 1089:220-226.
16. Schmidt, N. J. 1979. Cell culture techniques for diagnostic virology, p. 65- 
139. In E. 11. Lennette and N. J. Schmidt (ed.), Diagnostic procedures for 
viral, rickettsial and chlamydial infections. American Public Health Associ­
ation, Washington, D.C.
17. Sommergruber, W., G. Casari, F. Fessl, J. Seipelt, and T. Skern. 1994. The 
2A proteinase of human rhinovirus is a zinc containing enzyme. Virology 
204:815-818.
18. Tiwari, R. K., J. Kusari, R, Kum ar, and G. C. Sen. 1988. G ene induction by 
interferons and double-stranded RNA: selective inhibition by 2-aminopu- 
rinc. Mol. Cell. Biol. 8:4289-4294.
19. Van der Werf, S., J. Bradley, E. Wimmer, F, W. Studier, and J. J. Dunn.
1986, Synthesis of infectious poliovirus RNA  by purified T7 R N A  polymer­
ase. Proc. Natl. Acad. Sci. USA 83:2330-2334.
20. Witherell, G. W,, A. Gil, and E. Wimmer. 1993. Interaction o f  polypyrimidine 
tract binding protein with the encephalomyocarditis virus m R N A  internal 
ribosomal entry site. Biochemistry 32:8268-8275.
21. Ziegler, E., A. M. Borman, F. G. Deliat, H. D. Liebig, D. Jugovic, K. M. Kean, 
T. Skern, and E. Kuechler. 1995. Picornavirus 2A proteinase mediated stim­
ulation of internal initiation of translation is dependent on enzymatic activity 
and the cleavage of cellular products. Virology 213:549-557.
22. Ziegler, E., A. M. Borman, R. Kirchweger, T. Skern, and K. M. Kean. 1995. 
Foot-and-mouth disease virus Lb proteinase can stimulate rhinovirus and 
enterovirus IRES-driven translation and cleave several proteins of cellular 
and viral origin. J. Virol. 69:3465-3474.
23. Zinn, K., A, Keller, L. Whittemore, and T. Maniatis. 1988. 2-Aminopurine 
selectively inhibits the induction of fi-interferon, c~fos, and c-myc gene ex­
pression. Science 240:210-213.
